Source recordFED

KARMAZYN, Morris

Federal grants & contributions· Canadian Institutes of Health Research· FY2012· $618,440· ON

Description

Role of Cytochrome P450-dependent Arachidonic Acid Metabolites in Hypertrophy and Heart Failure

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$618,440$0Original · 2011-10-01 (start date) · total $618,440
  • #02011-10-01$618,440
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2011-10-01(start date)$618,440—Role of Cytochrome P450-dependent Arachidonic Acid Metabolites in Hypertrophy and Heart Failure

Related records · 4

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2014-2015-Q2-00577Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$686,220FY2015
236-2012-2013-Q4-00373Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$707,850FY2014
236-2012-2013-Q2-00016Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$745,884FY2013
236-2011-2012-Q4-00526Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$1,400,000FY2012

Cite as: Glassbox record view · Federal grants & contributions · 236-2011-2012-Q1-00422 · retrieved 2026-11-14.